RDC Clinical Pty Ltd
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS6
PHASE 3 / 2-30
RECRUITING3
READOUTS ≤12 MONTHS4
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| Levagen+ NCT07028528 |
P2 | Recruiting | Diabetic Peripheral Neuropathy | 80 | 2026-05 |
| Lavender Oil NCT07315516 |
P2 | Recruiting | Sleep Disorder (Disorder); Stress | 240 | 2027-02 |
| IMPTRP NCT07457723 |
P2 | Recruiting | Healthy Volunteers | 90 | 2027-03 |
| Maca Root NCT07816172 |
P2 | Not yet recruiting | Lower Urinary Tract Symptoms (LUTS) | 200 | 2027-08 |
| Palmitoylethanolamide (PEA) NCT06717867 |
P2 | Active, not recruiting | Healthy; Safety | 200 | 2027-08 (+7 mo) |
| NOURTI NCT07642648 |
P2 | Not yet recruiting | URTI; Common Cold | 300 | 2027-12 |